Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)

NCT05041907 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

3800

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Nirmatrelvir/ritonavir (e.g. PAXLOVID™)
DRUG: Nitazoxanide
DRUG: Molnupiravir and nirmatrelvir/ritonavir (e.g. PAXLOVID™)
DRUG: Hydroxychloroquine
OTHER: No treatment
DRUG: Monoclonal antibodies
DRUG: Fluoxetine
DRUG: Molnupiravir
DRUG: Sotrovimab
DRUG: Ensitrelvir
DRUG: Monoclonal antibodies
DRUG: Favipiravir
DRUG: Ivermectin
DRUG: Remdesivir
DRUG: Atilotrelvir/ritonavir
DRUG: Metformin
DRUG: Nirmatrelvir/ritonavir
DRUG: Nirmatrelvir/ritonavir
DRUG: Nirmatrelvir

Sponsor

University of Oxford